T Albrektsen
Overview
Explore the profile of T Albrektsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albrektsen T, Sorensen B, Hjorto G, Fleckner J, Rao L, Petersen L
J Thromb Haemost
. 2007 May;
5(8):1588-97.
PMID: 17470200
Background: Factor VIIa (FVIIa) binding to tissue factor (TF) induces cell signaling via the protease activity of FVIIa and protease-activated receptor 2 (PAR2). Objective: We examined how the gene-expression profile...
2.
Richter H, Albrektsen T, Billestrup N
J Mol Endocrinol
. 2003 Apr;
30(2):139-50.
PMID: 12683938
GH inhibits primary rat preadipocyte differentiation and expression of late genes required for terminal differentiation. Here we show that GH-mediated inhibition of fatty acid-binding protein aP2 gene expression correlates with...
3.
Albrektsen T, Richter H, Clausen J, Fleckner J
Biochem J
. 2001 Oct;
359(Pt 2):393-402.
PMID: 11583587
Adipocyte differentiation is co-ordinately regulated by several transcription factors and is accompanied by changes in the expression of a variety of genes. Using mRNA differential display analysis, we have isolated...
4.
Boel E, Albrektsen T, Fleckner J, Selmer J
Curr Pharm Biotechnol
. 2001 Jul;
1(1):63-71.
PMID: 11467362
The discovery of the important metabolic and physiological role played by a family of transcription factors, the peroxisome proliferator activated receptors (PPAR), has opened up for a new understanding of...
5.
Albrektsen T, Fleckner J
Mol Pharmacol
. 2001 Feb;
59(3):567-75.
PMID: 11179452
Thiazolidinediones (TZDs) are a new class of compounds that improve the insulin sensitivity in patients with non-insulin-dependent diabetes mellitus (NIDDM) as well as in rodent models of NIDDM. These compounds...
6.
Rehnmark S, Usuda N, Albrektsen T, Feltkamp D, Gustafsson J, Alexson S
J Biol Chem
. 1999 Aug;
274(33):23368-77.
PMID: 10438514
Brown adipose tissue (BAT) hyperplasia is a fundamental physiological response to cold; it involves an acute phase of mitotic cell growth followed by a prolonged differentiation phase. Peroxisome proliferator-activated receptors...
7.
Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson J
Mol Endocrinol
. 1998 Jun;
12(6):864-81.
PMID: 9626662
Transcriptional regulation of gene expression by nuclear receptors requires negatively and positively acting cofactors. Recent models for receptor activation propose that certain receptors in the absence of ligands can recruit...
8.
Walle P, Westergren G, Dimenas E, Olofsson B, Albrektsen T
J Clin Pharmacol
. 1994 Jul;
34(7):742-7.
PMID: 7929868
Central nervous system (CNS)-related symptoms and quality of life during treatment with controlled-release (CR) metoprolol and a standard formulation of atenolol were compared in a double-blind crossover study in 60...
9.
Vilsvik J, Ringdal N, Albrektsen T, Holthe S
Ann Allergy
. 1993 Apr;
70(4):300-4.
PMID: 8466095
One hundred fifty-nine asthmatic patients aged 19 to 76 years completed an open crossover-designed study comparing the acceptability of the Bricanyl Turbuhaler (BTH) and the Ventolin metered-dose inhaler (VMDI). The...
10.
Albrektsen T, Anmarkrud N
Eye (Lond)
. 1993 Jan;
7 ( Pt 4):511-6.
PMID: 8253229
The reason for the poorer prognosis of pseudoexfoliation syndrome glaucomas (PXSG) compared with primary open angle glaucomas (POAG) is not fully understood. An open, comparative, cross-over study was performed in...